Carcinoma, Ductal, Breast clinical trials at UC Health
2 research studies open to new patients

• Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

  open to eligible females ages 18 years and up

  Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.

  at UCSD

• Study of LOXO-101 (Larotrectinib) in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)

  open to eligible people ages 12 years and up

  Phase II, multi-center, open-label study of patients with advanced solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3.

  at UCLA

Last updated: February 13, 2019